+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Negative Pressure Wound Therapy Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4987157
  • Report
  • March 2020
  • Region: Global
  • 110 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now


  • 3M (Acelity L.P. Inc.)
  • Cardinal Health, Inc.
  • ConvaTec Inc.
  • DeRoyal Industries, Inc.
  • Devon Medical, Inc.
  • Medela AG
  • MORE
Negative pressure wound therapy is considered to be the most preferred choice of treatment, especially for deep acute wounds and persistent chronic wounds including leg ulcers.

The topical use of NPWT has been widely studied in the literature over the past 20 years. Most clinical trials have shown the effectiveness of this therapy in the treatment of superficial wounds. Moreover, the localized use of NPWT in infected wounds offers advantages, such as wound drainage, angiogenesis stimulation, proteinase excretion, and decreased local and systemic bacterial load. According to a study, published in the Journal of Trauma, it was found that NPWT augmented with silver dressings decreases infection.

Key Market Trends

Diabetic Foot Ulcers are Expected to Witness Rapid Growth in the Market Studied

Diabetic Foot Ulcers (DFU) is one of the most common complications associated with Diabetes and is posing a burden on several countries across the globe. The annual incidence of DFU across the globe is around 6.3%, as stated by the report from the American College of Physicians (ACP). Furthermore, the report suggests that the lifetime incidence of foot ulcers in diabetic patients is 19-34%. Several studies have revealed that NPWT is helpful in reducing the time it takes wounds to heal. Faster wound healing results in an overall decrease in hospitalization and avoids the additional morbidity of chronic wounds.

Hence, due to the efficacy of the NPWT in healing the DFU in less time, the demand for NPWT is increasing despite the high price of it. Added to that, rising incidence and prevalence of DFU across the globe are fuelling the segment growth.

North America Dominates the Market

Being one of the most developed economies and technologically advanced countries, the United States from the North America region is holding the largest share in the medical devices market which is a beneficial factor for the market studied. NPWT is an expensive procedure but the reimbursement policies in the North America region are better hence, the service or treatment availed by the patient becomes cheap compared to that of developing countries. Furthermore, this region has the presence of all the key players that are dominating the NPWT market. Therefore, owing to the aforementioned factors, North America is expected to have a significant share of the market studied.

Competitive Landscape

The market for NPWT is moderately competitive with the presence of most of the international companies. The big players in this market are focusing on technological advancements of their products to sustain in the market and increase competitiveness. For instance, in 2019, KCI, an Acelity Company has received FDA clearance for DERMATAC Drape, a significant advancement in NPWT, it conforms to different anatomical locations, adapting to the body and providing a tight, highly effective seal for 48 to 72 hours in uneven areas, for wound protection.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown
2 of 5


  • 3M (Acelity L.P. Inc.)
  • Cardinal Health, Inc.
  • ConvaTec Inc.
  • DeRoyal Industries, Inc.
  • Devon Medical, Inc.
  • Medela AG
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Accidents and Traumatic Events
4.2.2 Rising Chronic Wounds Such as Diabetic Foot Ulcers
4.2.3 Technological Advancements in the NPWT Devices
4.3 Market Restraints
4.3.1 High Cost of Device and Treatment
4.3.2 Complications Associated With NPWT Device
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Re-Usable Device
5.1.2 Single-Use Device
5.2 By Wound Type
5.2.1 Diabetic Foot Ulcer
5.2.2 Pressure Ulcer
5.2.3 Venous Leg Ulcer
5.2.4 Burn Wounds
5.2.5 Others
5.3 By End-user
5.3.1 Hospital
5.3.2 Homecare
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.2 3M (Acelity L.P. Inc.)
6.3 Talley Group Limited
6.4 Smith & Nephew plc
6.5 Devon Medical, Inc.
6.6 Molnlycke Health Care
6.7 Medela AG
6.8 DeRoyal Industries, Inc.
6.9 ConvaTec Inc.
6.10 Cardinal Health, Inc.
6.11 Paul Hartmann AG

Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • 3M (Acelity L.P. Inc.)
  • Talley Group Limited
  • Smith & Nephew plc
  • Devon Medical, Inc.
  • Molnlycke Health Care
  • Medela AG
  • DeRoyal Industries, Inc.
  • ConvaTec Inc.
  • Cardinal Health, Inc.
  • Paul Hartmann AG
Note: Product cover images may vary from those shown
5 of 5